Artemis Wealth Advisors, LLC Merck & Co., Inc. Transaction History

Artemis Wealth Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Aug 21, 2023	BUY	$84.53 - $94.96 $507 - $569	6 New	6 $0
Q2 2022 Aug 21, 2023	BUY	$83.49 - $94.64 $500 - $567	6 New	6 $0
Q2 2022 Aug 02, 2022	BUY	$83.49 - $94.64 $500 - $567	6 New	6 $1,000
Q4 2020 Feb 17, 2023	SELL	$71.77 - $79.65 $7,392 - $8,203	-103 Closed	0 $0
Q3 2020 Sep 05, 2023	BUY	$73.18 - $82.95 $7,537 - $8,543	103 New	103 $8,000
Q3 2020 Feb 17, 2023	BUY	$73.18 - $82.95 $7,098 - $8,046	97 Added 1616.67%	103 $9,000
Q4 2019 Sep 01, 2023	BUY	$77.58 - $87.54 $122,188 - $137,875	1,575 New	1,575 $136,000
Q4 2019 Feb 13, 2023	BUY	$77.58 - $87.54 $121,723 - $137,350	1,569 Added 26150.0%	1,575 $143,000

3,827

1.87B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $248B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Artemis Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Artemis Wealth Advisors, LLC with notifications on news.